The first draft guidance provides an initial framework for how the agency will assess AI models in drug development, but the ...

The US Food and Drug Administration (FDA) recently issued its draft guidance, Considerations for the Use of Artificial Intelligence to ...

AI is touching every industry, and healthcare is no exception: the global market size for healthcare AI, which was valued at ...

This post is part of MoFo’s 2025 Intersection of AI and Life Sciences blog series. In this blog series, we explore how ...

New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain ...

Recognizing the increased use of artificial intelligence in the development of new therapies, the U.S. FDA on Monday released separate draft guidance on the use of the technology in the ...

If finalized, it would be the first guidance from the FDA to provide comprehensive recommendations for AI-enabled devices throughout the total product lifecycle. The guidance would offer ...

The FDA has responded to the increasing use of artificial intelligence (AI) in the discovery and development of drugs and biologics by publishing its first provisional guidance on the technology's ...

The FDA is releasing the first-ever guidance on how the pharmaceutical industry can use AI. Justice Department releases ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

Proprio announced today that it entered into a strategic partnership with LifeHealthcare to distribute its AI surgical ...